Retour
Fourchette du Jour
14,43 €
15,00 €
Fourchette 52 Semaines
13,91 €
28,00 €
Volume
470 849
Moyenne 50J / 200J
16,56 €
/
22,06 €
Clôture Précédente
14,60 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 30,1 | 0,4 |
| P/B | 2,7 | 2,9 |
| ROE % | 9,3 | 3,8 |
| Net Margin % | 11,8 | 3,9 |
| Rev Growth 5Y % | 7,8 | 10,0 |
| D/E | 0,3 | 0,2 |
Objectif de Cours des Analystes
Hold
24,50 €
+65.5%
Low: 17,50 €
High: 32,00 €
P/E Prévisionnel
24,4
BPA Prévisionnel
0,61 €
Croissance BPA (est.)
+0,0%
CA Est.
1,3 B
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
1,24 €
1,22 € – 1,25 €
|
1,8 B | 1 |
| FY2029 |
1,09 €
1,08 € – 1,10 €
|
1,6 B | 1 |
| FY2028 |
0,90 €
0,89 € – 0,91 €
|
1,5 B | 1 |
Points Clés
Revenue grew 7,80% annually over 5 years — modest growth
Debt/Equity of 0,32 — conservative balance sheet
Generating 21,44M in free cash flow
P/E of 30,09 — premium valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 4,59%
Croissance
Revenue Growth (5Y)
7,80%
Revenue (1Y)3,21%
Earnings (1Y)14,01%
FCF Growth (3Y)N/A
Qualité
Return on Equity
9,29%
ROIC7,02%
Net Margin11,78%
Op. Margin16,07%
Sécurité
Debt / Equity
0,32
Current Ratio1,74
Interest Coverage8,40
Valorisation
P/E Ratio
30,09
P/B Ratio2,72
EV/EBITDA23,93
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 3,21% | Revenue Growth (3Y) | 2,46% |
| Earnings Growth (1Y) | 14,01% | Earnings Growth (3Y) | -3,98% |
| Revenue Growth (5Y) | 7,80% | Earnings Growth (5Y) | -0,01% |
| Profitability | |||
| Revenue (TTM) | 1,14B | Net Income (TTM) | 134,28M |
| ROE | 9,29% | ROA | 5,28% |
| Gross Margin | 28,99% | Operating Margin | 16,07% |
| Net Margin | 11,78% | Free Cash Flow (TTM) | 21,44M |
| ROIC | 7,02% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,32 | Current Ratio | 1,74 |
| Interest Coverage | 8,40 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 30,09 | P/B Ratio | 2,72 |
| P/S Ratio | 3,55 | PEG Ratio | 2,50 |
| EV/EBITDA | 23,93 | Dividend Yield | 0,00% |
| Market Cap | 4,04B | Enterprise Value | 4,38B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1,14B | 1,10B | 1,09B | 983,68M | 843,92M |
| Net Income | 134,28M | 117,78M | 145,63M | 142,85M | 134,32M |
| EPS (Diluted) | 0,49 | 0,43 | 0,55 | 0,53 | 0,53 |
| Gross Profit | 330,33M | 302,32M | 339,89M | 319,80M | 265,41M |
| Operating Income | 183,08M | 161,14M | 200,72M | 192,43M | 162,23M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 2,54B | 2,33B | 2,07B | 1,66B | 1,42B |
| Total Liabilities | 1,06B | 924,43M | 938,93M | 663,79M | 577,18M |
| Shareholders' Equity | 1,49B | 1,40B | 1,13B | 996,13M | 842,07M |
| Total Debt | 470,70M | 428,97M | 396,59M | 218,37M | 244,29M |
| Cash & Equivalents | 130,54M | 98,27M | 69,60M | 228,74M | 411,04M |
| Current Assets | 934,40M | 880,12M | 861,89M | 845,78M | 865,97M |
| Current Liabilities | 535,57M | 477,47M | 574,39M | 462,50M | 338,62M |